Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Physical Assessment
88%
Quality Improvement Initiatives
77%
Isoindolinone
58%
GW5074
49%
Cyclin-dependent Kinase
49%
Neuroprotective Action
49%
Clinical Practice
44%
Prevention Studies
44%
Medical Center
44%
Patient Outcomes
44%
GW8510
44%
Nursing Research
44%
Operant Conditioning
44%
PKR Inhibitor
44%
Texas
44%
Robotic Tutors
44%
Fall Prevention
44%
Imidazole-4
44%
Nurse Training
44%
Chemical Compounds
44%
Activating Transcription Factor 3 (ATF3)
44%
Neuronal Apoptosis
44%
Clinical Deterioration
44%
Histone Deacetylase 1 (HDAC1)
44%
Training Opportunities
44%
Amino
44%
Early Detection
44%
Neuronal Cell Death
44%
Neuroprotective Drugs
44%
Benzisothiazolinone
44%
Systems-based
44%
Synergism
44%
Enhancer of Split
44%
Direct Interaction
44%
Competency Assessment
44%
Rapid Response Team
44%
Cyclin-dependent Kinase Inhibitor
44%
B-Raf
44%
Reduced Mortality
44%
Methodist
35%
Neuroprotection
29%
Labor Shortage
22%
Robot Tutor
22%
Intelligent Robots
22%
Robot Tutoring
22%
New nurses
22%
Training Procedure
22%
Nursing Care
22%
Health Systems
22%
Hospital-based
22%
Neuroscience
Neuroprotective Agent
100%
Cyclin-Dependent Kinase
88%
Neuroapoptosis
44%
Enhancer Region
44%
Neuronal Cell Death
44%
Operant Conditioning
44%
Activating Transcription Factor 3
44%
Histone Deacetylase
44%
In Vitro
39%
Neuroprotection
39%
Cell Cycle Progression
33%
Programmed Cell Death
30%
Neurodegenerative Disorder
25%
Neurodegeneration
21%
Protein Kinase
19%
Cyclin Dependent Kinase 2
17%
Excitability
16%
Kinase
16%
Protein Kinase Inhibitor
15%
Protein Kinase R
14%
In Vivo
9%
Receptor Tyrosine Kinase
8%
Kinase Insert Domain Receptor
8%
Cell Cycle
8%
Behavior (Neuroscience)
8%
Death Associated Protein Kinase
7%
Amino Terminal Sequence
7%
Huntington's Disease
7%
P38 Mitogen-Activated Protein Kinases
7%
Cell Line
7%
Mitogen-Activated Protein Kinase Kinase
6%
Protein Kinase A
6%
Cell Signaling
6%
U0126
6%
Small Interfering RNA
6%
Decision-Making
5%
Feeding Behavior
5%
Pharmacology, Toxicology and Pharmaceutical Science
Neuroprotective Agent
97%
Cyclin Dependent Kinase
55%
3 (3,5 Dibromo 4 Hydroxybenzylidene) 1,3 Dihydro 5 Iodo 2 Indolone
55%
Cyclin Dependent Kinase Inhibitor
44%
Activating Transcription Factor 3
44%
Neuroprotection
34%
Indole
33%
Degenerative Disease
30%
Isotopes of Potassium
24%
Nerve Degeneration
22%
Phosphotransferase Inhibitor
22%
Cyclin Dependent Kinase 2
22%
Protein Kinase
18%
Protein Kinase R
17%
Protein Kinase Inhibitor
15%
Hyperkalemia
11%
2,3 Dihydro 2 Oxo 3 (4,5,6,7 Tetrahydro 1h Indol 2 Ylmethylene) 1h Indole 5 Sulfonic Acid Dimethylamide
11%
Protein Tyrosine Kinase
11%
Vasculotropin Receptor 2
11%
Reentry Arrhythmia
11%
Mitogen Activated Protein Kinase P38
8%
Initiation Factor 2
8%
Mouse Model
8%
Huntington Chorea
8%
Phosphotransferase
8%
Death Associated Protein Kinase
8%
